Moreover, the presence of Clostridium perfringens has been found to be enhanced in individuals with NMO compared to that in patients with MS and healthy controls [169] and potential molecular mimicry between this microorganism and AQP4 has been suggested [170]. This evidence concerns the gene AQP4 and myeloid sarcoma.